Lenacapavir (LEN) is an antiviral medication used to treat and prevent HIV/AIDS and was first approved for individuals with drug-resistant infections in 2022. While there is still no vaccine for the ...
Broadly neutralizing antibodies (bNAbs) are among the most promising new treatments for HIV, offering the potential to forego traditional daily doses of antiretroviral drugs. In one recent clinical ...
Every 15 minutes, someone in the U.S. dies from a drug-resistant superbug. A few decades from now, antibiotic-resistant bacterial infections threaten to become the leading cause of death worldwide, ...
Gloved fingers hold a labeled vial of lenacapavir, a clear, yellowish liquid. Lenacapavir (shown) is an antiretroviral medication used to help prevent and treat HIV. Credit: Associated Press While ...
An electronic 96-channel pipette was one of the tools used to scale up and allow the teamto perform over 7,000 parallel experiments that uncovered more than 100 bNAb escapemutations across 15 viral ...
Modern-day HIV treatments may stem from a genetic mutation dating back to the Viking Age, researchers said. Steinar Engeland via Unsplash On June 5, 1981, the Centers for Disease Control and ...
New findings shed light on what’s making the parasite less treatable using the drug that’s considered a first line of defense ...
Scientists have found that some viruses can deliberately generate genetic diversity to evade bacterial defences, offering a potential new clue for developing treatments when antibiotics fail. View on ...
In simple terms: a mutation is a stable change in genetic sequence that can be copied when cells or viruses replicate. Most mutations have no detectable effect, some contribute to disease, and a small ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results